Less metal - the latest evolution in PCI
- PMID: 39347106
- PMCID: PMC11413634
- DOI: 10.4244/AIJ-E-24-00004
Less metal - the latest evolution in PCI
Conflict of interest statement
S. Eccleshall received research grants for investigator-initiated research and lecture honoraria from B. Braun. He is a shareholder of MedAlliance and also acts as a consultant for B. Braun, Cordis, Medtronic, and MedAlliance. B. Scheller is a shareholder of InnoRa GmbH and received lecture fees and consulting honoraria from B.Braun and Medtronic.
Figures
References
-
- Shin ES, Jun EJ, Kim S, Kim B, Kim TH, Sohn CB, Her AY, Park Y, Cho JR, Jeong YH, Choi BJ. Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease. JACC Cardiovasc Interv. 2023;16:292–9. - PubMed
-
- Teo J, Tawfeq MN, Ahmad NF, Zainal Z, Wong S, Thum CH, Aris FA, Teh KC, Palaniappan G, Koh HB, Roslan A, Rusani B, Ganesan K, Hadi H. Hybrid strategy of drug-eluting stent and drug-coated balloon in the treatment of de novo coronary artery disease: 1-year clinical outcome. AsiaIntervention. 2024;10(3):212–218.
-
- Gao XF, Ge Z, Kong XQ, Chen X, Han L, Qian XS, Zuo GF, Wang ZM, Wang J, Song JX, Lin L, Pan T, Ye F, Wang Y, Zhang JJ, Chen SL ULTIMATE Ⅲ Investigators. Intravascular Ultrasound vs Angiography-Guided Drug-Coated Balloon Angioplasty: The ULTIMATE Trial. JACC Cardiovasc Interv. 2024;17:1519–28. - PubMed
-
- Ninomiya K, Serruys PW, Colombo A, Reimers B, Basavarajaiah S, Sharif F, Testa L, Di Mario, Nerla R, Ding D, Huang J, Kotoku N, Kageyama S, Kageyama M, Sevestre E, Fezzi S, Dijkstra J, O’Leary N, Morel MA, Garg S, Cortese B, Onuma Y. A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels. JACC Cardiovasc Interv. 2023;16:2884–96. - PubMed
-
- Scheller B, Zeller T. Paclitaxel-coated balloons: the more you gain the more you get. Eur Heart J. 2024 - PubMed
Publication types
LinkOut - more resources
Full Text Sources